F A deLuna

1.0k total citations
24 papers, 844 citations indexed

About

F A deLuna is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, F A deLuna has authored 24 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in F A deLuna's work include Bone health and treatments (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). F A deLuna is often cited by papers focused on Bone health and treatments (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). F A deLuna collaborates with scholars based in United States and Japan. F A deLuna's co-authors include Jiunn H. Lin, Dominick J. Tocco, A E Duncan, I‐Wu Chen, E H Ulm, Joy A. Nishime, M Hichens, Masato Chiba, W.J.A. Vandenheuvel and Yuh J. Lin and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Pharmaceutical Research.

In The Last Decade

F A deLuna

24 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F A deLuna United States 15 292 218 166 164 130 24 844
J H Lin United States 13 325 1.1× 209 1.0× 192 1.2× 146 0.9× 107 0.8× 17 769
J.Chris Jensen Germany 16 226 0.8× 172 0.8× 334 2.0× 108 0.7× 172 1.3× 24 1.0k
Hwi‐yeol Yun South Korea 17 154 0.5× 158 0.7× 129 0.8× 194 1.2× 136 1.0× 107 925
Donald P. Cooper United Kingdom 25 154 0.5× 69 0.3× 39 0.2× 916 5.6× 142 1.1× 59 1.7k
G. H. Hottendorf United States 18 172 0.6× 54 0.2× 96 0.6× 175 1.1× 284 2.2× 44 819
Susan K. Paulson United States 17 95 0.3× 152 0.7× 136 0.8× 170 1.0× 464 3.6× 31 1.7k
Raul M. Alfaro United States 18 171 0.6× 274 1.3× 306 1.8× 128 0.8× 110 0.8× 25 981
I Bekersky United States 17 149 0.5× 156 0.7× 105 0.6× 185 1.1× 123 0.9× 37 814
Stacy C. Dilzer United States 18 217 0.7× 252 1.2× 145 0.9× 253 1.5× 382 2.9× 25 1.3k
Nasir Idkaidek Jordan 17 111 0.4× 36 0.2× 123 0.7× 109 0.7× 174 1.3× 70 840

Countries citing papers authored by F A deLuna

Since Specialization
Citations

This map shows the geographic impact of F A deLuna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F A deLuna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F A deLuna more than expected).

Fields of papers citing papers by F A deLuna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F A deLuna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F A deLuna. The network helps show where F A deLuna may publish in the future.

Co-authorship network of co-authors of F A deLuna

This figure shows the co-authorship network connecting the top 25 collaborators of F A deLuna. A scholar is included among the top collaborators of F A deLuna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F A deLuna. F A deLuna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stone, Julie A., Xin Xu, Gregory A. Winchell, et al.. (2004). Disposition of Caspofungin: Role of Distribution in Determining Pharmacokinetics in Plasma. Antimicrobial Agents and Chemotherapy. 48(3). 815–823. 111 indexed citations
2.
Lin, Jiunn H., I‐Wu Chen, Masato Chiba, Joy A. Nishime, & F A deLuna. (2000). Route-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme Inactivation. Drug Metabolism and Disposition. 28(4). 460–466. 11 indexed citations
3.
Balani, Suresh K., Xin Xu, Byron H. Arison, et al.. (2000). Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine. Drug Metabolism and Disposition. 28(11). 1274–1278. 80 indexed citations
4.
Lin, Jiunn H., Masato Chiba, I‐Wu Chen, et al.. (1999). Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction. Drug Metabolism and Disposition. 27(10). 1187–1193. 34 indexed citations
5.
Balani, Suresh K., et al.. (1999). Nonlinear Pharmacokinetics of Efavirenz (DMP-266), a Potent HIV-1 Reverse Transcriptase Inhibitor, in Rats and Monkeys. Drug Metabolism and Disposition. 27(1). 41–45. 36 indexed citations
6.
Lin, Jiunn H., et al.. (1994). Nonlinear kinetics of alendronate. Plasma protein binding and bone uptake.. Drug Metabolism and Disposition. 22(3). 400–405. 28 indexed citations
7.
Lin, Jiunn H., I‐Wu Chen, & F A deLuna. (1994). On the Absorption of Alendronate in Rats. Journal of Pharmaceutical Sciences. 83(12). 1741–1746. 60 indexed citations
8.
Lin, J H, et al.. (1993). Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.. Journal of Pharmacology and Experimental Therapeutics. 267(2). 670–675. 22 indexed citations
9.
Lin, Jiunn H., et al.. (1993). Uptake of alendronate by bone tissue in hypocalcemic and hypercalcemic rats.. Drug Metabolism and Disposition. 21(5). 800–804. 9 indexed citations
10.
Lin, Jiunn H., et al.. (1992). Renal handling of alendronate in rats. An uncharacterized renal transport system.. Drug Metabolism and Disposition. 20(4). 608–613. 46 indexed citations
11.
Lin, Jiunn H., I‐Wu Chen, & F A deLuna. (1991). Dose-Dependent Pharmacokinetics of MK-417, a Potent Carbonic Anhydrase Inhibitor, in Experimental Polycythemic and Anemic Rats. Pharmaceutical Research. 8(5). 608–614. 7 indexed citations
12.
Lin, J H, F A deLuna, E H Ulm, & Dominick J. Tocco. (1990). Species-dependent enantioselective plasma protein binding of MK-571, a potent leukotriene D4 antagonist.. Drug Metabolism and Disposition. 18(4). 484–487. 14 indexed citations
13.
Tocco, Dominick J., et al.. (1990). Interspecies differences in stereoselective protein binding and clearance of MK-571.. Drug Metabolism and Disposition. 18(4). 388–392. 25 indexed citations
14.
Lin, Jiunn H., F A deLuna, Dominick J. Tocco, & E H Ulm. (1989). Effect of experimental diabetes on elimination kinetics of diflunisal in rats.. Drug Metabolism and Disposition. 17(2). 147–152. 10 indexed citations
15.
Tocco, Dominick J., A E Duncan, F A deLuna, & Gregory J. Wells. (1988). The physiological disposition of aerosolized 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate (L-648,051) in rats.. Drug Metabolism and Disposition. 16(5). 697–700. 1 indexed citations
16.
Tocco, Dominick J., et al.. (1980). Uptake of the Beta-Adrenergic Blocking Agents Propranolol and Timolol by Rodent Brain. Journal of Cardiovascular Pharmacology. 2(2). 133–144. 13 indexed citations
17.
Tocco, Dominick J., F A deLuna, A E Duncan, et al.. (1979). Physiological disposition and metabolism of 2-aminomethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride.. Drug Metabolism and Disposition. 7(5). 330–334. 3 indexed citations
18.
Tocco, Dominick J., K F Hooke, F A deLuna, & A E Duncan. (1976). Stereospecific binding of timolol, a beta-adrenergic blocking agent.. Drug Metabolism and Disposition. 4(4). 323–329. 17 indexed citations
19.
Tocco, Dominick J., et al.. (1975). PHYSIOLOGICAL DISPOSITION AND METABOLISM OF TIMOLOL IN MAN AND LABORATORY ANIMALS. Drug Metabolism and Disposition. 3(5). 361–370. 74 indexed citations
20.
Tocco, Dominick J., F A deLuna, & A E Duncan. (1975). Electron-Capture GLC Determination of Timolol in Human Plasma and Urine. Journal of Pharmaceutical Sciences. 64(11). 1879–1881. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J H Lin Breakdown of academic impact, for papers by J.Chris Jensen Breakdown of academic impact, for papers by Hwi‐yeol Yun Breakdown of academic impact, for papers by Donald P. Cooper Breakdown of academic impact, for papers by G. H. Hottendorf Breakdown of academic impact, for papers by Susan K. Paulson Breakdown of academic impact, for papers by Raul M. Alfaro Breakdown of academic impact, for papers by I Bekersky Breakdown of academic impact, for papers by Stacy C. Dilzer Breakdown of academic impact, for papers by Nasir Idkaidek
Rankless by CCL
2026